ZA964215B - Fatty acid treatment - Google Patents
Fatty acid treatmentInfo
- Publication number
- ZA964215B ZA964215B ZA964215A ZA964215A ZA964215B ZA 964215 B ZA964215 B ZA 964215B ZA 964215 A ZA964215 A ZA 964215A ZA 964215 A ZA964215 A ZA 964215A ZA 964215 B ZA964215 B ZA 964215B
- Authority
- ZA
- South Africa
- Prior art keywords
- pct
- fatty acid
- acid treatment
- sec
- fatty acids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Fats And Perfumes (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9510636.5A GB9510636D0 (en) | 1995-05-25 | 1995-05-25 | Fatty acid treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA964215B true ZA964215B (en) | 1996-12-04 |
Family
ID=10775045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA964215A ZA964215B (en) | 1995-05-25 | 1996-05-24 | Fatty acid treatment |
Country Status (17)
Country | Link |
---|---|
US (1) | US6150411A (xx) |
EP (1) | EP0774962B1 (xx) |
JP (1) | JPH10503531A (xx) |
KR (1) | KR970704433A (xx) |
AT (1) | ATE264676T1 (xx) |
AU (1) | AU722474B2 (xx) |
CA (1) | CA2195979A1 (xx) |
DE (1) | DE69632236T2 (xx) |
DK (1) | DK0774962T3 (xx) |
ES (1) | ES2217317T3 (xx) |
FI (1) | FI970298A0 (xx) |
GB (1) | GB9510636D0 (xx) |
HK (1) | HK1012575A1 (xx) |
NO (1) | NO970317L (xx) |
PT (1) | PT774962E (xx) |
WO (1) | WO1996037200A1 (xx) |
ZA (1) | ZA964215B (xx) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102090636A (zh) * | 1998-10-15 | 2011-06-15 | Dsm公司 | Pufa增补剂 |
KR100341109B1 (ko) * | 1999-03-10 | 2002-06-20 | 이인수 | 인식력 및 기억력 증강용 식이 조성물 |
US7112609B2 (en) * | 1999-06-01 | 2006-09-26 | Drugtech Corporation | Nutritional supplements |
US6258846B1 (en) * | 1999-06-01 | 2001-07-10 | Drugtech Corporation | Nutritional supplements |
GB9918023D0 (en) | 1999-07-30 | 1999-09-29 | Unilever Plc | Skin care composition |
US6479545B1 (en) * | 1999-09-30 | 2002-11-12 | Drugtech Corporation | Formulation for menopausal women |
GB9923738D0 (en) * | 1999-10-07 | 1999-12-08 | Nestle Sa | Nutritional composition |
ATE363486T1 (de) | 2001-07-27 | 2007-06-15 | Neptune Technologies & Bioress | Flavonoide und mehrfach ungesättigte fettsäuren enthaltende natürliche phospholipide maritimen ursprungs sowie deren anwendungen |
US7935365B2 (en) | 2003-10-22 | 2011-05-03 | Enzymotec, Ltd. | Glycerophospholipids for the improvement of cognitive functions |
US20050130937A1 (en) | 2003-10-22 | 2005-06-16 | Enzymotec Ltd. | Lipids containing omega-3 and omega-6 fatty acids |
US8052992B2 (en) | 2003-10-22 | 2011-11-08 | Enzymotec Ltd. | Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions |
TWI365716B (en) * | 2003-12-02 | 2012-06-11 | Suntory Holdings Ltd | Oil or fat and oil compositions containing phospholipids and a long-chain polyunsaturated fatty acid supply compound, and food using same |
JP2007524674A (ja) * | 2004-01-19 | 2007-08-30 | マーテック・バイオサイエンシーズ・コーポレーション | リーリン欠損症または機能障害およびそれに関連する方法 |
US7998500B2 (en) | 2005-08-04 | 2011-08-16 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for women |
US8202546B2 (en) | 2005-08-04 | 2012-06-19 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
US7901710B2 (en) | 2005-08-04 | 2011-03-08 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
US8263137B2 (en) | 2005-08-04 | 2012-09-11 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for women |
US20070166411A1 (en) * | 2005-12-16 | 2007-07-19 | Bristol-Myers Squibb Company | Nutritional supplement containing long-chain polyunsaturated fatty acids |
US8343753B2 (en) * | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
GB0813599D0 (en) * | 2008-07-24 | 2008-09-03 | Pharma Marine As | Method |
PT2493478T (pt) | 2009-10-29 | 2018-04-03 | Acasti Pharma Inc | Composições terapêuticas concentradas de fosfolípidos |
US9119826B2 (en) | 2011-02-16 | 2015-09-01 | Pivotal Therapeutics, Inc. | Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels |
US8951514B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels |
US8715648B2 (en) | 2011-02-16 | 2014-05-06 | Pivotal Therapeutics Inc. | Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics |
US8952000B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events |
US9233114B2 (en) | 2013-12-05 | 2016-01-12 | Buriva, LLC | Dietary supplement containing phospholipid-DHA derived from eggs |
US9610302B2 (en) | 2013-12-05 | 2017-04-04 | Buriva, LLC. | Composition containing phospholipid-DHA and B vitamins |
US9549937B2 (en) | 2013-12-05 | 2017-01-24 | Burvia, LLC. | Composition containing phospholipid-DHA and folate |
US9216199B2 (en) | 2013-12-05 | 2015-12-22 | Buriva, LLC | Nutritional supplement containing phospholipid-DHA derived from eggs |
BR112018073060A2 (pt) * | 2016-06-01 | 2019-04-09 | Nestec S.A. | composição para uso na profilaxia de doença alérgica |
WO2023102170A1 (en) * | 2021-12-02 | 2023-06-08 | The Regents Of The University Of California | Compositions and methods for inhibiting seizures |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9224809D0 (en) * | 1992-11-26 | 1993-01-13 | Scotia Holdings Plc | Schizophrenia |
EP0711503A3 (en) * | 1994-11-14 | 1997-11-26 | Scotia Holdings Plc | Milk fortified with GLA and/or DGLA |
-
1995
- 1995-05-25 GB GBGB9510636.5A patent/GB9510636D0/en active Pending
-
1996
- 1996-05-24 ZA ZA964215A patent/ZA964215B/xx unknown
- 1996-05-24 DE DE69632236T patent/DE69632236T2/de not_active Expired - Fee Related
- 1996-05-24 JP JP8535515A patent/JPH10503531A/ja not_active Ceased
- 1996-05-24 AT AT96919911T patent/ATE264676T1/de not_active IP Right Cessation
- 1996-05-24 ES ES96919911T patent/ES2217317T3/es not_active Expired - Lifetime
- 1996-05-24 WO PCT/GB1996/001265 patent/WO1996037200A1/en active IP Right Grant
- 1996-05-24 PT PT96919911T patent/PT774962E/pt unknown
- 1996-05-24 CA CA002195979A patent/CA2195979A1/en not_active Abandoned
- 1996-05-24 US US08/776,250 patent/US6150411A/en not_active Expired - Lifetime
- 1996-05-24 KR KR1019970700488A patent/KR970704433A/ko active IP Right Grant
- 1996-05-24 DK DK96919911T patent/DK0774962T3/da active
- 1996-05-24 AU AU58277/96A patent/AU722474B2/en not_active Ceased
- 1996-05-24 EP EP96919911A patent/EP0774962B1/en not_active Expired - Lifetime
-
1997
- 1997-01-24 NO NO970317A patent/NO970317L/no not_active Application Discontinuation
- 1997-01-24 FI FI970298A patent/FI970298A0/fi unknown
-
1998
- 1998-12-18 HK HK98113985A patent/HK1012575A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO970317D0 (no) | 1997-01-24 |
AU722474B2 (en) | 2000-08-03 |
DE69632236T2 (de) | 2005-04-14 |
ES2217317T3 (es) | 2004-11-01 |
ATE264676T1 (de) | 2004-05-15 |
FI970298A (fi) | 1997-01-24 |
CA2195979A1 (en) | 1996-11-28 |
NO970317L (no) | 1997-01-24 |
DK0774962T3 (da) | 2004-08-09 |
FI970298A0 (fi) | 1997-01-24 |
WO1996037200A1 (en) | 1996-11-28 |
HK1012575A1 (en) | 1999-08-06 |
DE69632236D1 (de) | 2004-05-27 |
JPH10503531A (ja) | 1998-03-31 |
EP0774962A1 (en) | 1997-05-28 |
AU5827796A (en) | 1996-12-11 |
KR970704433A (ko) | 1997-09-06 |
EP0774962B1 (en) | 2004-04-21 |
GB9510636D0 (en) | 1995-07-19 |
PT774962E (pt) | 2004-09-30 |
US6150411A (en) | 2000-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA964215B (en) | Fatty acid treatment | |
GB9220667D0 (en) | Improvements in or relating to dioic acids | |
NO942351D0 (xx) | ||
ZA967626B (en) | Lipid extract having anti-inflammatory activity. | |
AU6915396A (en) | Multiple sclerosis treatment | |
ATE207352T1 (de) | Nicht-allosterische gaba a agonisten zur behandlung von schlafstörungen | |
NO971037D0 (no) | Trifenyletylener til beskyttelse mot behandling av osteoporose | |
IL114446A (en) | Pharmaceutical preparation for pain management and process for its preparation | |
PT920323E (pt) | Nova utilizacao de fosfolipidos de origem animal em terapeutica e/ou dietetica | |
GB9204414D0 (en) | Method of treatment | |
NZ506681A (en) | Disinfecting composition | |
DE69800859D1 (de) | Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen | |
DE69427116T2 (de) | Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis | |
GR3032727T3 (en) | Aqueous prolonged release formulation | |
DE59202373D1 (en) | N-acyl-phosphatidylethanolamin als oxidationsschutzmittel. | |
UA29506C2 (uk) | Лікувально-косметичний засіб "фіто-пелоїд" | |
AU1195497A (en) | Use of alpha,alpha-diphenylacetic acid-4-(n-methyl-piperidyl)ester as anti-spasmodic |